Green Cures Buy Hold or Sell Recommendation

GRCU -- USA Stock  

USD 0.002  0.000008  0.40%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Green Cures Botanical Distribution is 'Strong Sell'. Macroaxis provides Green Cures buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GRCU positions. The advice algorithm takes into account all of Green Cures Botanical available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from GRCU buy-and-hold prospective. Please also check Green Cures Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell Green CuresBuy Green Cures
Strong Sell


Hype Condition

Current Valuation

Odds of Distress

Analyst Consensus

Not Available
For the selected time horizon Green Cures Botanical Distribution has a mean deviation of 7.24, semi deviation of 0.0, standard deviation of 11.43, variance of 130.62, downside variance of 0.0 and semi variance of 0.0
We provide buy, hold, or sell suggestion to complement the regular expert consensus on Green Cures. Our dynamic recommendation engine utilizes multi - dimensional algorithm to analyze the organization potential to grow using all technical and fundamental data available at the time. To make sure Green Cures Botanical Distribution is not overpriced, please check out all Green Cures fundamentals including its Revenue and the relationship between Cash per Share and Total Asset . As Green Cures Botanical appears to be a penny stock we also urge to confirm its Price to Sales numbers.

Green Cures Trading Alerts and Improvement Suggestions

Green Cures generates negative expected return over the last 30 days
Green Cures has high historical volatility and very poor performance
Green Cures has some characteristics of a very speculative penny stock
Green Cures has high likelihood to experience some financial distress in the next 2 years

Green Cures Returns Distribution Density

Mean Return0.21Value At Risk19.05
Potential Upside11.54Standard Deviation11.43
 Return Density 

Green Cures Greeks

Alpha over DOW
Beta against DOW=2.76
Overall volatility
Information ratio =0.03

Green Cures Volatility Alert

Green Cures Botanical Distribution is displaying above average volatility of 11.43 over selected time horizon. Investors should scrutinize Green Cures Botanical Distribution independently to make sure intended market timing strategies are aligned with expectations about Green Cures volatility. Green Cures Botanical Distribution is a penny stock. Even though Green Cures may be a good instrument to invest, many penny stocks are speculative instruments that are subject to artificial stock promotions. Please make sure you fully understand upside and downside potential of investing in Green Cures Botanical Distribution or similar risky assets. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings,sudden promotions and many other similar artificial hype indicators. We also encourage traders to check work history of company executives before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that has been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The one and only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
 Better Than Average     
 Worse Than Average Compare Green Cures to competition

Green Cures Fundamental Vs Peers

FundamentalsGreen CuresPeer Average
Return On Equity54.62% (0.31)%
Return On Asset2.30% (0.14)%
Profit Margin496.44% (1.27)%
Operating Margin62.22% (5.51)%
Current Valuation41.33M16.62B
Shares Owned by Institutions0.02% 39.21%
Price to Sales3.74X11.42X
Gross Profit989.6K27.38B
Net Income6.14M570.98M
Cash and Equivalents80K2.7B
Cash per Share0.04X5.01X
Total Debt3.1M5.32B
Debt to Equity9.10% 48.70%
Current Ratio4.85X2.16X
Book Value Per Share(2.23)X1.93K
Cash Flow from Operations80K971.22M
Earnings Per Share3.15X3.12X
Number of Employees2018.84K
Market Capitalization4.62M19.03B
Total Asset1K29.47B
Retained Earnings(1.58M)9.33B
Working Capital(539K)1.48B
Current Liabilities539K7.9B